CA
NZ
UK
AU
IND
US
Genmab (NASDAQ:GMAB) said on October 28, 2026 that a Phase 3 trial of its investigational therapy petosemtamab met its goal in head and neck cancer. The company reported a 50% reduction in the risk of death for patients who received petosemtamab plus pembrolizumab, compared …
Axogen (NASDAQ:AXGN) reported third-quarter results on October 28, 2026 and raised its full-year revenue forecast to at least USD 290 million, according to the company release. Third-quarter revenue grew 26.2% from a year earlier. The shares rose 31.5% on the day, according to published …
OrthoPediatrics (NASDAQ:KIDS) reported record third-quarter revenue of USD 72.7 million on October 28, 2026, up 19% from a year earlier, according to the company release. It also raised its full-year revenue forecast to USD 270 million to USD 273 million. The shares were up …
Replimune (NASDAQ:REPL) reported fiscal second-quarter results on October 28, 2026, and the shares rose 23.8% on the day, according to published market data. In the release, the company said its cancer therapy has been available in the United States since early October. The reading …
Bicara Therapeutics (NASDAQ:BCAX) fell 45% on October 28, 2026, according to published market data. Inhibrx Biosciences (NASDAQ:INBX) fell 24% on the same day. They were the two largest unexplained biotech declines of the session, meaning that a search of company releases and filings found …
Rapport Therapeutics (NASDAQ:RAPP) announced a pricing of about USD 175 million of common stock at USD 21.00 per share on October 28, 2026, along with about USD 150 million of convertible notes. The prior close was USD 27.54, so the stock offering was priced …
The European Central Bank (ECB) said on Thursday that President Christine Lagarde has resigned and will step down from her position on February 7, 2027. Lagarde has led the euro area's central bank since 2019. Her term was due to end in October 2027.
Abeona Therapeutics (NASDAQ:ABEO) shares are trading 2.66% higher at $4.57 on Wednesday, October 28, 2026, an implied prior close of about $4.45 (calculated). At that price the market capitalization is roughly $261 million (calculated from 57.18 million shares).
Six AI and robotics names are moving on Wednesday, October 28, 2026. Braiin (NASDAQ:BRAI) is trading 43.19% higher at $4.74 after the launch of its Force AI contact-centre layer. Kodiak AI (NASDAQ:KDK) is trading 10.44% higher at $1.24 with no dated release behind the …
Akebia Therapeutics (NASDAQ:AKBA) shares are trading 4.92% higher at $0.69 on Wednesday, October 28, 2026, among the most heavily traded penny stocks of the session. No company release dated October 28 explains the advance. At a quote near $0.69, the stock was down about …
Please wait processing your request...